Archive for May 9th, 2011

Clinical updates for GTXI OREX MDVN CHTP

May 09, 2011 No Comments by

GTx, Inc. (Nasdaq: GTXI) today provided a company update and maintained previous guidance that they intend to initiate two pivotal Phase 3 trials OstarineTM (GTx-024) for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer during 3Q this year. They also intend to initiate a Phase 2b trial of CapesarisTM […]

Daily News Read more